Cargando…
Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
BACKGROUND: Statins have several effects beyond their well-known antihyperlipidemic activity, which include immunomodulatory, antioxidative and anticoagulant effects. In this study, we have tested the possible antimicrobial activity of statins against a range of standard bacterial strains and bacter...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408379/ https://www.ncbi.nlm.nih.gov/pubmed/22564676 http://dx.doi.org/10.1186/1476-0711-11-13 |
_version_ | 1782239448693473280 |
---|---|
author | Masadeh, Majed Mhaidat, Nizar Alzoubi, Karem Al-azzam, Sayer Alnasser, Ziad |
author_facet | Masadeh, Majed Mhaidat, Nizar Alzoubi, Karem Al-azzam, Sayer Alnasser, Ziad |
author_sort | Masadeh, Majed |
collection | PubMed |
description | BACKGROUND: Statins have several effects beyond their well-known antihyperlipidemic activity, which include immunomodulatory, antioxidative and anticoagulant effects. In this study, we have tested the possible antimicrobial activity of statins against a range of standard bacterial strains and bacterial clinical isolates. METHODS: Minimum inhibitory concentrations (MIC) values were evaluated and compared among three members of the statins drug (atorvastatin, simvastatin, and rosuvastatin). RESULTS: It was revealed that statins are able to induce variable degrees of antibacterial activity with atorvastatin, and simvastatin being the more potent than rosuvastatin. Methicillin-sensitive staphylococcus aureus (MSSA), methicillin-resistant staphylococcus aureus (MRSA), vancomycin-susceptible enterococci (VSE), vancomycin-resistant enterococcus (VRE), acinetobacter baumannii, staphylococcus epidermidis, and enterobacter aerogenes, were more sensitive to both atorvastatin, and simvastatin compared to rosuvastatin. On the other hand, escherichia coli, proteus mirabilis, and enterobacter cloacae were more sensitive to atorvastatin compared to both simvastatin and rosuvastatin. Furthermore, most clinical isolates were less sensitive to statins compared to their corresponding standard strains. CONCLUSION: Our findings might raise the possibility of a potentially important antibacterial class effect for statins especially, atorvastatin and simvastatin. |
format | Online Article Text |
id | pubmed-3408379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34083792012-07-31 Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin Masadeh, Majed Mhaidat, Nizar Alzoubi, Karem Al-azzam, Sayer Alnasser, Ziad Ann Clin Microbiol Antimicrob Research BACKGROUND: Statins have several effects beyond their well-known antihyperlipidemic activity, which include immunomodulatory, antioxidative and anticoagulant effects. In this study, we have tested the possible antimicrobial activity of statins against a range of standard bacterial strains and bacterial clinical isolates. METHODS: Minimum inhibitory concentrations (MIC) values were evaluated and compared among three members of the statins drug (atorvastatin, simvastatin, and rosuvastatin). RESULTS: It was revealed that statins are able to induce variable degrees of antibacterial activity with atorvastatin, and simvastatin being the more potent than rosuvastatin. Methicillin-sensitive staphylococcus aureus (MSSA), methicillin-resistant staphylococcus aureus (MRSA), vancomycin-susceptible enterococci (VSE), vancomycin-resistant enterococcus (VRE), acinetobacter baumannii, staphylococcus epidermidis, and enterobacter aerogenes, were more sensitive to both atorvastatin, and simvastatin compared to rosuvastatin. On the other hand, escherichia coli, proteus mirabilis, and enterobacter cloacae were more sensitive to atorvastatin compared to both simvastatin and rosuvastatin. Furthermore, most clinical isolates were less sensitive to statins compared to their corresponding standard strains. CONCLUSION: Our findings might raise the possibility of a potentially important antibacterial class effect for statins especially, atorvastatin and simvastatin. BioMed Central 2012-05-07 /pmc/articles/PMC3408379/ /pubmed/22564676 http://dx.doi.org/10.1186/1476-0711-11-13 Text en Copyright ©2012 Masadeh et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Masadeh, Majed Mhaidat, Nizar Alzoubi, Karem Al-azzam, Sayer Alnasser, Ziad Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin |
title | Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin |
title_full | Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin |
title_fullStr | Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin |
title_full_unstemmed | Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin |
title_short | Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin |
title_sort | antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408379/ https://www.ncbi.nlm.nih.gov/pubmed/22564676 http://dx.doi.org/10.1186/1476-0711-11-13 |
work_keys_str_mv | AT masadehmajed antibacterialactivityofstatinsacomparativestudyofatorvastatinsimvastatinandrosuvastatin AT mhaidatnizar antibacterialactivityofstatinsacomparativestudyofatorvastatinsimvastatinandrosuvastatin AT alzoubikarem antibacterialactivityofstatinsacomparativestudyofatorvastatinsimvastatinandrosuvastatin AT alazzamsayer antibacterialactivityofstatinsacomparativestudyofatorvastatinsimvastatinandrosuvastatin AT alnasserziad antibacterialactivityofstatinsacomparativestudyofatorvastatinsimvastatinandrosuvastatin |